• SENSEX 82,253.46
    -247.01 (--0.30%)
  • BANKNIFTY 56,765.35
    10.65 (+0.02%)
  • Ola Electric
    47.78 157.53(%)
  • JP Power Ven.
    27.62 24.86(%)
  • Reliance Industr
    1,479.35 1,115.55(%)
  • ICICI Bank
    1,424.70 1,471.10(%)
  • Infosys
    1,560.00 1,307.10(%)
  • Neuland Labs.
    14,767.20 18,089.55(%)
  • Eternal Ltd
    277.65 304.50(%)
  • M & M
    3,104.90 3,276.30(%)
  • Enviro Infra
    288.50 392.00(%)
  • Waaree Energies
    3,235.00 3,740.75(%)
  • Hind. Unilever
    2,492.60 2,136.00(%)
  • John Cockerill
    4,911.60 6,324.70(%)
  • Crizac
    321.15 275.00(%)
  • Jio Financial
    317.55 198.60(%)
  • Sai Life
    825.80 840.35(%)
  • Hind.Aeronautics
    4,913.70 5,580.00(%)
  • TCS
    3,200.50 3,060.25(%)
  • Garden Reach Sh.
    2,644.85 1,180.10(%)
  • Sambhv Steel
    115.63 96.17(%)
  • Indiamart Inter.
    2,772.00 3,198.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Hikal Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Kalyani
  • BSE Code : 4401.0
  • ISIN : INE475B01022
342.85 2 (0.69%)
  • As on 14 Jul 2025 (EOD)

  • Today’s Low

    336.40

  • Today’s High

    345.70

  • Open

    340.00

  • Perv Close

    340.50

  • 52W Low

    309.15

  • 52W High

    464.75

Key Indicators

  • P/E(TTM)

    46.23

  • Mar.Cap (₹Cr.)

    4,198.39

  • Div & Yield %

    0.41

  • Book Value(₹)

    102.36

  • Debt-Equity Ratio

    0.69

  • AGM Date

    14-Jul-2025

  • EPS

    7.37

  • P/E Ratio

    46.23

Financials Ratios

  • Debt-Equity Ratio

    0.67

  • Mar.Cap (₹Cr.)

    4,198.39

  • RONW (%)

    6.00

  • ROCE (%)

    7.51

Score Board

  • Equity (₹ in Cr.)

    24.66

  • BV (₹)

    102.40

  • Sales( ₹ in Cr.)

    1,843.50

  • NP (in Cr.)

    90.90

  • NP Var(%)

    31.0

  • Div%

    70.0

  • CPS (₹)

    18.30

  • EPS (₹)

    7.40

  • Traded Value (₹ in Lakhs)

    4,200.86

  • 52 Week High

    464.75

  • 52 Week Low

    309.15

  • Price BSE

    341.0

  • Price NSE

    341.00

  • Market Capital( in Cr.)

    4,200.86

  • P/C Ratio

    18.70

  • P/E Ratio

    46.30

  • Price Vs.BV

    7.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,784.60 2,023.03 1,942.72 1,720.44 1,507.26 1,589.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,784.60 2,023.03 1,942.72 1,720.44 1,507.26 1,589.61
Other Income 2.45 5.41 4.89 4.98 3.70 2.26
Stock Adjustments -19.51 14.56 35.82 -1.67 5.58 14.98
Total Income 1,767.54 2,043.00 1,983.43 1,723.75 1,516.54 1,606.85
EXPENDITURE :            
Raw Materials 805.15 1,121.59 1,032.21 906.71 781.90 868.80
Power and Fuel Cost 170.16 186.91 175.46 147.83 129.99 132.04
Employee Cost 243.98 220.40 201.35 164.32 156.57 135.69
Other Manufacturing Expenses 136.52 114.60 106.37 91.27 93.71 90.24
Selling and Administration Expenses 116.24 110.01 101.31 64.05 55.56 52.50
Miscellaneous Expenses 26.10 27.02 21.28 21.71 37.35 27.19
Employee Benefit Expenses 243.98 220.40 201.35 164.32 156.57 135.69
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,498.14 1,780.53 1,637.98 1,395.88 1,255.08 1,306.46
Operating Profit 269.40 262.47 345.46 327.87 261.46 300.40
Interest 56.37 48.10 31.22 36.20 52.42 58.43
Gross Profit 213.03 214.37 314.24 291.67 209.04 241.97
Depreciation 117.61 109.01 95.67 85.25 82.46 92.88
Profit Before Tax 95.42 105.36 218.57 206.42 126.58 149.09
Current Tax 28.37 30.48 59.65 79.55 34.70 45.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.47 -3.49 -1.59 -6.27 7.44 0.51
Reported Net Profit 69.51 78.38 160.51 133.14 84.44 103.08
Extraordinary Items 0.37 0.45 0.14 0.01 -10.36 -0.02
Adjusted Net Profit 69.14 77.93 160.37 133.13 94.80 103.10
Adjustment below Net Profit -0.65 -0.60 1.19 -1.44 -4.19 -2.65
P & L Balance brought forward 870.05 804.60 670.03 553.12 492.61 405.75
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 14.80 12.33 27.13 14.80 19.73 13.56
P & L Balance carried down 924.11 870.05 804.60 670.03 553.12 492.61
Dividend 0.00 0.00 0.00 2.47 12.33 7.40
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 60.00 60.00 80.00 100.00 60.00 60.00
Dividend Per Share(Rs) 1.20 1.20 1.60 2.00 1.20 1.20
Earnings Per Share-Unit Curr 5.64 6.36 13.02 10.80 6.85 8.36
Earnings Per Share(Adj)-Unit Curr 5.64 6.36 13.02 10.80 6.85 8.36
Book Value 96.32 91.93 86.62 75.70 66.22 61.33
Book Value(Adj)-Unit Curr 96.32 91.93 86.62 75.70 66.22 61.33

Shareholding Pattern

  • Promoter Group

    68.85%

  • Public Share Holding

    31.15%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 72,172,664 58.53 72,172,664 7
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,895,100 9.65 11,895,100 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 825,000 0.67 825,000 8
Others 0 0.00 0 0
Sub Total 84,892,764 68.85 84,892,764 22
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 250 0.00 250 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 30 0.00 30 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,020,818 5.69 7,020,818 76
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 3,614,091 2.93 3,614,091 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,068,461 0.87 1,068,461 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 11,703,650 9.49 11,703,650 92
2] Non Institution
Bodies Corporate 2,059,685 1.67 2,059,685 345
Clearing Members 3,490 0.00 3,490 4
Directors of their Relatives 449,010 0.36 449,010 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,121,288 1.72 2,121,288 1,476
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,009,004 0.82 1,009,004 1,307
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,532,388 2.05 2,532,388 8
Individuals holding nominal share capital up to Rs. 1 lakh 17,903,624 14.52 17,771,162 65,590
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 18,515 0.02 18,515 2
Others 393,101 0.32 393,101 6
Sub Total 26,704,336 21.66 26,571,874 68,793
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 123,300,750 100.00 123,168,288 68,907

Company Background

Hikal LtdPharmaceuticals - Indian - Bulk Drugs

  • Hikal Ltd
  • BSE Code : 4401.0
  • ISIN : INE475B01022

  • Incorporation Year

    1988

  • Registered Office

    717/718 Maker Chamber V
    7th Floor Nariman Point, Mumbai,
    Maharashtra-400021

  • Telephone

    91-022-3926 7100/62770477

  • FAX

    91-022-2283 3913

  • Chairman

    Sameer Hiremath

  • Managing Director

  • Company Secretary

    Rajasekhar Reddy

  • Auditor

    S R B C & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Hikal Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Hikal 340.70 1,787.05 1,784.60 46.23 7.51
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10